| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 6, 2024 | CNS Pharmaceuticals, Inc. | CEO | Buy | 91.3 | +166,666 | 340.07% | ✗ | $50K |
| Aug 16, 2023 | Aug 16, 2023 | CNS Pharmaceuticals, Inc. | CEO | Buy | 85.0 | +2,750 | 5.94% | ✗ | $4.9K |
| Apr 12, 2023 | Apr 14, 2023 | CNS Pharmaceuticals, Inc. | CEO | Buy | 91.3 | +15,000 | 49.98% | ✗ | $10.4K |